TTUHSC School of Medicine
HomeSchool of MedicineInternal MedicineFaculty




Profile for Vaqar Ahmed, MD

Vaqar Ahmed

Vaqar Ahmed, MD

  • Hypertension Specialist
  • Medical Director
  • Assistant Professor
  • Attending Nephrologist
Office Phone: 806-743-3150
Email: vaqar.ahmed@ttuhsc.edu
Mail Address: 3601 4th Street
Lubbock TX 79430

Positions:

  • Hypertension Specialist, American Society of Hypertension -Present
  • Medical Director, University Medical Center Lubbock, TX 2013-Present
  • Assistant Professor, Texas Tech University Health Sciences Center Lubbock, TX 2013-Present
  • Attending Nephrologist, Texas Tech University Health Sciences Center Lubbock, TX 2013-Present
  • Clinical Assistant Professor, UW School of Medicine and Public Health Madison, WI 2007-2010

Post Doctoral Education:

  • Transplant Nephrology Fellow: Medical University of South Carolina, 2013
  • Nephrology Fellow: Medical University of South Carolina, 2012
  • Resident: Michael Reese Hospital, 2007
  • Intern: Michael Reese Hospital, 2005
  • Internship: Hamdard University Hospital, 2001

Education:

  • MD: Hamdard College of Medicine and Dentistry, 2001

Selected Publications:

  • Srisung, W & Mankongpaisarnrung, C & Anaele, C & Dumrongmongcolgul, N & Ahmed, Vaqar January (2015) A Rare Case of Low-Solute Hyponatremia in a Nonalcoholic Person Case Reports in Nephrology and Dialysis, 5, 1.
  • Ahmed, Vaqar & Kuppachi, C & Thomas, B & Sultan, A & Egidi, M November (2011) Therapeutic Options for Recurrent Focal Segmental Glomerulosclerosis after Kidney Transplantation- The Need for Multicenter Trials JASN Abstract Supplement, 22.

Selected Presentations:

  • Poster: Calcific Uremic Arteriolopathy successfully treated with Sodium Thiosulfate National Kidney Foundation, Dallas, TX; 2015.
  • Tissue proteomics Reveals Protein Differences Associated with Allograft Cellular Rejection American Transplant Congress, Seattle, WA; 2013.
  • Poster: Cryptosporidiosis in an Adult Simultaneous Kidney-Pancreas Transplant Patient National Kidney Foundation, Orlando, FL; 2013.
  • Poster: Viral Co-Infection in Renal Transplant Recipients National Kidney Foundation, Orlando, FL; 2013.
  • Poster: Hydroxychloroquine Induced Cardiomyopathy Society of General Internal Medicine, Denver, CO; April 2013.

Selected Contracts and Grants:

  • FibroGen Protocol FGCL-4592-063: A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of the Efficacy and Safety of FG-4592 in the Treatment of Anemia in Incident-dialysis Patients 2015-
    Awarded by
    in the amount of $0
    Supporting

  • FibroGen Protocol FGCL-4592-064: A Phase 3, Multicenter, Randomized, Open- Label, Active-Controlled Study of the Efficacy and Safety of Roxadustat (FG-4592) in the Maintenance Treatment of Anemia in End Stage Renal Disease (ESRD) Subjects on Stable Dialysis 2015-
    Awarded by
    in the amount of $0
    Supporting

  • A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects with Chronic Kidney Disease on Hemodialysis 2014-
    Awarded by
    in the amount of $0


  • A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy - M11-352-SONAR: Study of Diabetic Nephropathy with Atrasentan 2014-
    Awarded by
    in the amount of $0


  • Retrospective analysis to determine if HLA matching and particularly DR matching has an impact on graft outcomes using contemporary immunosuppressive protocols -2011
    Awarded by
    in the amount of $0
    Principal
    Research Related

Selected Scheduled Teaching:

  • In-Patient Internal Medicine Service - 2014
  • Internal Medicine Residency Subspecialty Conference - 2014
  • Nephrology Fellowship Conferences - 2014
  • System Disorder 1 - Spring 2014
  • Nephrology Fellowship Program - Fall 2013

Selected Non-Credit Instruction Taught:

  • Chronic Kidney Disease for Primary Care Providers - 2015
  • Chronic Kidney Disease Prevention & Treatment - 2014
Date last updated: 7/22/2015
©